“Moderna is well-prepared for the launch of its second respiratory vaccine, which will build upon the success of its commercial efforts in the fall COVID-19 market,” the company wrote.
Its second vaccine will be the “only pre-filled syringe” vaccine once it launches, which the drugmakers says will save pharmacists and clinicians time.
The FDA is expected to respond to Moderna’s RSV Biologics License Application by May 12. From there, if approved, it will move forward to the CDC’s Advisory Committee on Immunization Practices to be reviewed at its June meeting.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
